Minakem, the contract manufacturing division of Minafin, specialized in custom development and manufacturing of building blocks, intermediates and active pharmaceutical ingredients (APIs) for the pharmaceutical industry, has initiated the extension of its manufacturing capacity at its Dunkirk site in France. The $18 million investment from parent company Minafin is the first of this magnitude. It will enable the company to set up a new production line, increasing production capacity by 28 cub...